Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest Profit Margin (TRIB, AXK, BLUD, VIVO)

Below are the top small-cap diagnostic substance stocks on the NYSE, the NASDAQ and the AMEX in terms of profit margin. The trailing-twelve-month profit margin at Trinity Biotech plc

is 59.32%. TRIB's PEG ratio is 1.60. The trailing-twelve-month profit margin at Accelr8 Technology Corporation

is 41.57%. AXK's ROE for the same period is 26.45%. The trailing-twelve-month profit margin at Immucor Inc

is 25.57%. BLUD's ROE for the same period is 18.07%. The trailing-twelve-month profit margin at Meridian Bioscience Inc

is 18.63%. VIVO's PEG ratio is 1.85.